Basit öğe kaydını göster

dc.contributor.authorHiltunen, S
dc.contributor.authorLindgren, E
dc.contributor.authorSilvis, SM
dc.contributor.authorHeldner, MR
dc.contributor.authorSerrano, F
dc.contributor.authorZelano, J
dc.contributor.authorZuurbier, SM
dc.contributor.authorMansour, M
dc.contributor.authorAguiar, de
dc.contributor.authorYesilot, Nilüfer
dc.contributor.authorGhiasian, M
dc.contributor.authorBarboza, MA
dc.contributor.authorArnao, V
dc.contributor.authorAridon, P
dc.contributor.authorPunter, MNM
dc.contributor.authorFerro, JM
dc.contributor.authorArauz, A
dc.contributor.authorTatlisumak, T
dc.contributor.authorArnold, M
dc.contributor.authorPutaala, J
dc.contributor.authorJood, K
dc.contributor.authorCoutinho, JM
dc.contributor.authorCanhão, P
dc.contributor.authorAl-Asady, S
dc.contributor.authorRedfors, P
dc.contributor.authorEkizoglu, Esme
dc.contributor.authorSánchez, van
dc.date.accessioned2021-03-02T16:48:25Z
dc.date.available2021-03-02T16:48:25Z
dc.identifier.citationSánchez v., Lindgren E., Silvis S., Hiltunen S., Heldner M., Serrano F., Zelano J., Zuurbier S., Mansour M., Aguiar d., et al., "Late seizures in cerebral venous thrombosis.", Neurology, cilt.95, 2020
dc.identifier.issn0028-3878
dc.identifier.othervv_1032021
dc.identifier.otherav_98aa309b-450e-4bcf-92c1-b1908027b912
dc.identifier.urihttp://hdl.handle.net/20.500.12627/3373
dc.identifier.urihttps://doi.org/10.1212/wnl.0000000000010576
dc.description.abstractObjective To examine the incidence, characteristics, treatment, and predictors of late seizures (LS) after cerebral venous thrombosis (CVT), we described these features in a registry of 1,127 patients with CVT. Methods We included consecutive adult patients from an international consortium of 12 hospital-based CVT registries. We excluded patients with a history of epilepsy or with 7 days after diagnosis of CVT. We used multivariable Cox regression to identify predictors of LS. Results We included 1,127 patients with CVT. During a median follow-up of 2.0 years (interquartile range [IQR] 1.0-6.3), 123 patients (11%) experienced >= 1 LS (incidence rate for first LS 30 per 1,000 person-years, 95% confidence interval [CI] 25-35). Median time to first LS was 5 months (IQR 1-16 months). Baseline predictors of LS included status epilepticus in the acute phase (hazard ratio [HR] 7.0, 95% CI 3.9-12.6), decompressive hemicraniectomy (HR 4.2, 95% CI 2.4-7.3), acute seizure(s) without status epilepticus (HR 4.1, 95% CI 2.5-6.5), subdural hematoma (HR 2.3, 95% CI 1.1-4.9), and intracerebral hemorrhage (HR 1.9, 95% CI 1.1-3.1). Eighty-five patients (70% of patients with LS) experienced a recurrent seizure during follow-up, despite the fact that 94% received antiepileptic drug treatment after the first LS. Conclusion During a median follow-up of 2 years, approximate to 1 in 10 patients with CVT had LS. Patients with baseline intracranial bleeding, patients with acute symptomatic seizures, and those who underwent decompressive hemicraniectomy were at increased risk of developing LS. The high recurrence risk of LS justifies epilepsy diagnosis after a first LS.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectKLİNİK NEUROLOJİ
dc.titleLate seizures in cerebral venous thrombosis.
dc.typeMakale
dc.relation.journalNeurology
dc.contributor.department, ,
dc.identifier.volume95
dc.contributor.firstauthorID2260416


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster